Drug intelligence / Profile preview

Borrasoft

Development stage: Unknown
Lead developer: Amato Pharmaceutical Products
Modality: Small Molecules
Administration: Topical

Overview

Borrasoft is a topical protective balm developed and marketed by Amato Pharmaceutical Products, specifically designed for perianal skin care. It is part of the Borraginol line of products, which is a leading brand for hemorrhoid care in Japan. The product is formulated with high-purity white petrolatum, which functions as an occlusive emollient to create a physical barrier on the skin. This barrier protects the sensitive anal area from irritation caused by moisture, friction, and fecal matter, thereby providing relief and preventing further discomfort in individuals suffering from hemorrhoids or related conditions. In Japan, it is categorized as a cosmetic product intended for skin protection.

Brand names: Borrasoft
Other names: Borrasoft protective balm

Beyond the preview

Go deeper on Borrasoft.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Borrasoft.

Explore the full profile